Major pharma manufacturers have a 29 September deadline to adjust their drug prices relative to other developed countries.

When Tidmarsh was appointed to CDER, the FDA emphasised his academic and clinical credentials – including his role as ...

BenchSci, a world leader in AI solutions for preclinical research and drug discovery, today announced that Mikael Dolsten, M.D., Ph.D., has joined its board of directors.

The global Biosurgery Market, valued at US$14.96 billion in 2024 stood at US$15.83 billion in 2025 and is projected to ...

Google will spend $85 billion on artificial-intelligence projects this year. Its rivals are likely to spend more.

Pfizer has concluded a global licensing agreement with 3SBio, excluding China, which grants it exclusive rights for the 3SBio’s SSGJ-707.

June was a slower month on the pharma agency side, but were several hires worth reporting, as well as a couple of interesting ...

While FDA Commissioner Marty Makary emphasizes learning and humility, the FDA has systematically removed the very experience ...

The advanced heart failure market is experiencing significant expansion, driven by increasing disease awareness, rising prevalence, and breakthrough therapies from key pharmaceutical companies such as ...